Detalhe da pesquisa
1.
Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group.
BMC Cancer
; 22(1): 701, 2022 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752779
2.
Treatment with octreotide in patients with well-differentiated neuroendocrine tumors of the ileum: prognostic stratification with Ga-68-DOTA-TATE positron emission tomography.
Mol Imaging
; 13: 1-10, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24824963
3.
Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.
J Neurooncol
; 110(3): 389-95, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23054562
4.
Irradiation and bevacizumab in high-grade glioma retreatment settings.
Int J Radiat Oncol Biol Phys
; 82(1): 67-76, 2012 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21030162
5.
FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status.
Radiother Oncol
; 104(1): 78-82, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22673727
6.
FET-PET for malignant glioma treatment planning.
Radiother Oncol
; 99(1): 44-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21458093
7.
[Advanced radioiodine-refractory differentiated thyroid cancer]. / Das fortgeschrittene Radioiod-refraktäre differenzierte Schilddrüsenkarzinom.
Dtsch Med Wochenschr
; 140(3): 168-71, 2015 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-25658401
8.
Intranasal delivery of cells to the brain.
Eur J Cell Biol
; 88(6): 315-24, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19324456